Unlock instant, AI-driven research and patent intelligence for your innovation.

CFTR with a partially deleted R domain and uses thereof

a technology of cftr and r domain, which is applied in the field of dna molecules encoding partially deleted cftr, can solve the problems of inefficient gene transfer from the apical surface of differentiated airway epithelia, small size of aav vector that can be inserted, and inefficient gene transfer

Inactive Publication Date: 2009-09-10
UNIV OF IOWA RES FOUND
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention offers new therapies for treating Cystic Fibrosis (CF) by using novel DNA molecules and proteins encoded by the DNA molecules. The DNA molecules have a partially deleted R domain, which is important for the function of the CFTR protein. The partially deleted R domain is capable of normal targeting to the apical membrane, wild-type biosynthesis, and generating transepithelial Cl− current in CF epithelia. The CFTR protein comprising a partially deleted R domain corrects the Cl− transport defect in a CF subject when expression in their nasal mucosa. The invention provides a functional chloride ion channel in CF airway epithelia cells and has low constitutive Cl− current. The DNA molecule may also include other deletions as long as it maintains the ability to provide a functional chloride ion channel.

Problems solved by technology

However, with most vectors two main problems limit gene transfer: gene transfer from the apical surface of differentiated airway epithelia is inefficient, and DNA molecule expression is transient.
One limitation of AAV vectors is the small size of a DNA molecule that can be inserted.
However, their utility in differentiated airway epithelia and in vivo is uncertain.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • CFTR with a partially deleted R domain and uses thereof
  • CFTR with a partially deleted R domain and uses thereof
  • CFTR with a partially deleted R domain and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

Construction of CFTR Variants

[0057]DNA molecules encoding exemplary embodiments of CFTR proteins comprising partial deletions in the R domain were made in pTM1-CFTR4 by PCR deletion mutagenesis (Quik Change Mutagenesis™, Stratagene, La Jolla, Calif.) and confirmed by sequencing. Constructs were ligated into an adenovirus serotype 5 vector in which the CMV promoter drives cDNA expression. The exemplary CFTR proteins were named by the residues that were deleted; for example in Δ708-835, residues between and including aa 708 and 835 are deleted. An identical adenovirus expressing green fluorescent protein (GFP) was used as a negative control. FIG. 1A shows the eight variants constructed which include, Δ708-835 (SEQ ID NO:9), Δ708-759 (SEQ ID NO: 10), Δ708-723 / 749-783 / 832-835 (SEQ ID NO:11), Δ708-723 / 749-783 / 819-835 (SEQ ID NO:12), Δ708-759 / 819-835 (SEQ ID NO:13), Δ760-835 (SEQ ID NO: 14), Δ708-783 (SEQ ID NO:15), and Δ708-783 / 823-835 (SEQ ID NO: 16). FIG. 1A indicates the deletions by ...

example 2

Protein Biochemistry

[0058]To confirm protein size and phosphorylation, HeLa cells were infected with 200 MOI of recombinant adenovirus in Eagles minimal essential media (EMEM) for 45 min. Cells were lysed 18-24 hr later, CFTR immunoprecipitated, and phosphorylated with γ-32P-ATP and the catalytic subunit of PKA as described previously. Baldursson et al., 2001, J. Biol. Chem. 276:1904-1910. For pulse chase studies, HeLa cells were infected as above, and after 18-24 hr cells were methionine starved, labeled with 35S-methionine, and pulse-chase studies carried out as described previously (Ostedgaard, Zeiher & Welsh, 1999, J. Cell Sci. 112:2091-2098. Proteins were separated on 8% SDS-PAGE, stained, destained, dried and exposed to phosphorscreens. After phosphorimaging, counts in bands B (immature) and C (mature) were quantitated. FIGS. 4A&B show that two representative CFTR proteins of the present invention comprising partially deleted R domains, namely Δ708-759 and Δ708-723 / 749-783 / 832...

example 3

Well-Differentiated CF Airway Epithelia

[0059]Cultures of human airway epithelia were obtained from CF bronchus (μF508 / μF508 or μF508 / other genotypes) and cultured at the air-liquid interface as previously described (Karp et al., 2002, Epithelial Cell Culture Protocols, ed. Wice (Human, Totowa, N.J.) 188:115-137, incorporated herein by reference. Epithelia were used at least 14 days after seeding when they were well-differentiated with a surface consisting of ciliated cells, goblet cells and other non-ciliated cells. They also retained the functional properties of airway epithelia including transepithelial electrolyte transport and resistance. FIG. 2 shows the short circuit current in well-differentiated airway epithelia in the presence of wild-type CFTR and GFP, demonstrating that wild-type CFTR can provide a functional chloride ion channel in CF airway epithelia. Bars at top of FIG. 2 indicate additions to solutions (detailed below in Example 5). Zero current level is shown by dash...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
currentaaaaaaaaaa
pHaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

The present invention offers new therapies for treating Cystic Fibrosis (CF), that are based on novel DNA molecules and proteins encoded by the DNA molecules. The present invention features DNA molecules encoding CFTR having a partially deleted R domain. The partial deletions in the R domain are between residues 708 and 835 of the wild-type CFTR.

Description

CROSS REFERENCE TO RELATED APPLICATIONS[0001]This is a divisional application of U.S. Ser. No. 10 / 367,507 filed Feb. 14, 2004, which is a nonprovisional application claiming priority under 35 U.S.C. § 119(e) to Provisional Application No. 60 / 358,074, filed on Feb. 19, 2002.GRANT REFERENCE[0002]This invention was made in part with government support from the National Heart, Lung and Blood Institute (NHLBI). Therefore the United States Government has certain rights in the invention.FIELD OF THE INVENTION[0003]This invention relates to DNA molecules encoding partially deleted CFTR and the CFTR proteins encoded thereby which are useful for treating cystic fibrosis (CF) airway disease.BACKGROUND OF THE INVENTION[0004]Various attempts have been made develop gene therapy for cystic fibrosis (CF) airway disease.[0005]Airway disease is the major cause of morbidity and mortality in cystic fibrosis (CF), an autosomal recessive disease caused by mutations in the gene encoding the cystic fibrosi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C07K14/705C07K14/47
CPCC07K14/4712
Inventor WELSH, MICHAEL J.OSTEDGAARD, LYNDA S.ZABNER, JOSEPH
Owner UNIV OF IOWA RES FOUND